These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography-mass spectrometry. Takahashi M; Nagashima M; Suzuki J; Seto T; Yasuda I; Yoshida T Talanta; 2009 Feb; 77(4):1245-72. PubMed ID: 19084633 [TBL] [Abstract][Full Text] [Related]
5. Development of a rapid LC-MS/MS method for direct urinalysis of designer drugs. Bell C; George C; Kicman AT; Traynor A Drug Test Anal; 2011; 3(7-8):496-504. PubMed ID: 21744513 [TBL] [Abstract][Full Text] [Related]
7. Hepatotoxicity of piperazine designer drugs: up-regulation of key enzymes of cholesterol and lipid biosynthesis. Arbo MD; Melega S; Stöber R; Schug M; Rempel E; Rahnenführer J; Godoy P; Reif R; Cadenas C; de Lourdes Bastos M; Carmo H; Hengstler JG Arch Toxicol; 2016 Dec; 90(12):3045-3060. PubMed ID: 26821219 [TBL] [Abstract][Full Text] [Related]
8. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges. Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687 [TBL] [Abstract][Full Text] [Related]
9. Detection of 1-benzylpiperazine and 1-(3-trifluoromethylphenyl)-piperazine in urine analysis specimens using GC-MS and LC-ESI-MS. Vorce SP; Holler JM; Levine B; Past MR J Anal Toxicol; 2008; 32(6):444-50. PubMed ID: 18652752 [TBL] [Abstract][Full Text] [Related]
10. Combined use of liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) and high performance liquid chromatography with photodiode array detector (HPLC-DAD) in systematic toxicological analysis. Broecker S; Pragst F; Bakdash A; Herre S; Tsokos M Forensic Sci Int; 2011 Oct; 212(1-3):215-26. PubMed ID: 21764531 [TBL] [Abstract][Full Text] [Related]
11. Determination of 32 cathinone derivatives and other designer drugs in serum by comprehensive LC-QQQ-MS/MS analysis. Swortwood MJ; Boland DM; DeCaprio AP Anal Bioanal Chem; 2013 Feb; 405(4):1383-97. PubMed ID: 23180084 [TBL] [Abstract][Full Text] [Related]
12. Chromatography as Method for Analytical Confirmation of Paracetamol in Postmortem Material Together with Psychoactive Substances. Biscevic-Tokic J; Tokic N; Ibrahimpasic E Acta Inform Med; 2015 Oct; 23(5):322-5. PubMed ID: 26635443 [TBL] [Abstract][Full Text] [Related]
13. Piperazine compounds as drugs of abuse. Arbo MD; Bastos ML; Carmo HF Drug Alcohol Depend; 2012 May; 122(3):174-85. PubMed ID: 22071119 [TBL] [Abstract][Full Text] [Related]
14. Low resolution and high resolution MS for studies on the metabolism and toxicological detection of the new psychoactive substance methoxypiperamide (MeOP). Meyer MR; Holderbaum A; Kavanagh P; Maurer HH J Mass Spectrom; 2015 Oct; 50(10):1163-74. PubMed ID: 26456786 [TBL] [Abstract][Full Text] [Related]
15. Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market. de Boer D; Bosman IJ; Hidvégi E; Manzoni C; Benkö AA; dos Reys LJ; Maes RA Forensic Sci Int; 2001 Sep; 121(1-2):47-56. PubMed ID: 11516887 [TBL] [Abstract][Full Text] [Related]
16. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine. Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nishikawa M; Nakajima K; Tsuchihashi H J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):315-22. PubMed ID: 15833296 [TBL] [Abstract][Full Text] [Related]
17. LC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum. Wohlfarth A; Weinmann W; Dresen S Anal Bioanal Chem; 2010 Apr; 396(7):2403-14. PubMed ID: 20069283 [TBL] [Abstract][Full Text] [Related]
18. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MS Michely JA; Brandt SD; Meyer MR; Maurer HH Anal Bioanal Chem; 2017 Feb; 409(6):1681-1695. PubMed ID: 27933361 [TBL] [Abstract][Full Text] [Related]
19. Metabolism of designer drugs of abuse. Staack RF; Maurer HH Curr Drug Metab; 2005 Jun; 6(3):259-74. PubMed ID: 15975043 [TBL] [Abstract][Full Text] [Related]
20. [Metabolism of designer drugs. Piperazine derivatives]. Melent'ev AB; Kataev SS Sud Med Ekspert; 2015; 58(4):49-55. PubMed ID: 26521316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]